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Idiopathic retroperitoneal fibrosis (IRF) is a rare disease often
causing obstructive uropathy. We evaluated the
clinicopathologic features of 24 patients with IRF to
characterize the histopathology of the disease and to provide
a framework for the differential diagnosis with other
retroperitoneal fibrosing conditions. Retroperitoneal
specimens were analyzed by light and electron microscopy
and by immunohistochemistry. Most patients presented with
abdominal/lumbar pain, constitutional symptoms, and high
acute-phase reactants. Overall, 20 had ureteral involvement
and 13 developed acute renal failure. The retroperitoneal
tissue consisted of a fibrous component and a chronic
inflammatory infiltrate with the former characterized by
myofibroblasts within a type-I collagen matrix. The infiltrate
displayed perivascular and diffuse patterns containing
lymphocytes, macrophages, plasma cells, and eosinophils.
The perivascular aggregates had a central core of CD20þ
cells and a mantle of CD3þ cells in equal proportions. In the
areas of diffuse infiltrate, CD3þ cells outnumbered the
CD20þ cells. Most plasma cells were positive for the IgG4
isotype. Small vessel vasculitis was found in the specimens of
11 patients. Our study indicates that a sclerotic background
with myofibroblasts associated with a diffuse and
perivascular infiltrate mainly consisting of T and B
lymphocytes may be a pathological hallmark of IRF.
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First described by Ormond1 as a distinct entity, idiopathic
retroperitoneal fibrosis (IRF) is characterized by an over-
production of fibro-inflammatory tissue that usually deve-
lops in the periaortic retroperitoneum and, in the late stages,
involves abdominal organs or structures such as the ureters.
IRF is a rare disorder, with a prevalence of 1.4/100 000
inhabitants and an incidence of 0.1/100 000 person-years.2–4
IRF has an insidious clinical onset characterized by flank,
back or abdominal pain, and constitutional symptoms such
as malaise, fever, anorexia, and weight loss.5,6 The laboratory
findings often reflect an acute-phase reaction, with high
erythrocyte sedimentation rate (ESR) and C-reactive protein
(CRP) levels; autoantibodies are also sometimes positive.
Ureteral obstruction causing acute or chronic renal insuffi-
ciency is the most common and severe complication of IRF.
About 80–100% of IRF patients show ureteral involvement:
this is bilateral in most cases, and in patients with unilateral
obstruction contralateral disease may develop within weeks
to months. Additionally, some patients present with non-
functioning kidneys, as a result of long-lasting obstructive
uropathy.5,7,8
Computed tomography (CT) and magnetic resonance
imaging (MRI) are considered to be the imaging modalities
of choice for the diagnosis of IRF because they are non-
invasive and provide a picture of the disease, which is
typically that of a periaortic mass of soft-tissue density
extending from the level of the renal arteries to the iliac
vessels and frequently causing medial ureteral deviation and
obstruction;3,9 atypical peripancreatic, periureteral, or pelvic
localizations have also been reported.3
However, the histological examination of the retroper-
itoneal tissue is still the most reliable diagnostic tool because
it may rule out other lesions of malignant, benign, or
infectious origin whose imaging pictures may mimic IRF. The
histological characteristics of IRF are not yet well defined:
only a few pathological descriptions have been reported in
the English language literature, and most of them are limited
to single case reports or small case series.5,10–14 In addition,
they often do not provide clues to differentiate IRF from
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other fibrous tissue-producing disorders, and there is a lack
of adequate clinical data.
In this study, we examined the morphological and clinical
characteristics of a large series of IRF patients, particularly
focusing on the histopathological, immunohistochemical,
and ultrastructural aspects of its fibrous and inflammatory
components, to provide a tool for the differential diagnosis
with other retroperitoneal disorders that may mimic IRF on
imaging studies.
RESULTS
Clinical features
The study sample consisted of 16 men (67%) and eight
women (33%), aged 30–77 years (median, 56) (Table 1).
At the time of disease onset, 21 patients (88%)
complained of pain (e.g., abdominal and back pain) and 19
(79%) presented with constitutional symptoms such as
malaise, anorexia, weight loss, and fever. Hydrocele and/or
varicocele were present in 11 of the 16 (69%) men; two (8%)
patients had deep vein thrombosis of the lower limbs, and
three (13%) constipation.
Twenty (83%) patients had ureteral involvement, which
was bilateral in 12 (60%) and unilateral in eight (40%); four
of the patients with initially unilateral ureteral involvement
developed contralateral obstruction after a median of 4
months (range 1–10 months). Thirteen (54%) patients had
acute renal failure (median creatinine 7 mg/dl, range 1.4–12).
At presentation, two patients had evidence of urinary tract
infection (Escherichia coli was isolated in one case, whereas
in the other one culture was not done) complicating
hydronephrosis; two patients also showed microscopic
hematuria.
Twenty-two (92%) had a high ESR (median 91 mm/h;
range 35–124) and 19 (79%) high CRP levels (median 27 mg/l,
range 11–182; normal o5). Ten (42%) patients were
antinuclear antibody-positive. Anti-thyroperoxidase and/or
anti-thyroglobulin antibodies were positive in six (25%)
patients, all of whom had ultrasound signs of diffuse chronic
thyroiditis; two other patients had ultrasound evidence of
thyroiditis but were negative for anti-thyroglobulin/thyroper-
oxidase antibodies. None of the patients with thyroidal
involvement underwent thyroid biopsy or fine needle
aspiration because of the absence of clear clinical indications.
Six patients (25%) were positive for anti-smooth muscle
antibodies, two for rheumatoid factor, one for anti-neutrophil
cytoplasmic antibodies (perinuclear anti-neutrophil cytoplas-
mic and anti-myeloperoxidase antibodies), and one for anti-
Ro antibodies. C3 and C4 levels were always normal. The
patients were treated with steroids and/or tamoxifen and/or
immunosuppressive drugs, according to ongoing study
protocols; 15 were enrolled in a currently ongoing prospective
randomized clinical trial (clinicaltrials.gov ID NCT00440349);
of the remaining nine patients, three were included in a
recently published retrospective study,15 three did not receive
any treatment, two received a short course of steroids, and
one was lost to follow-up after 2 months.
Ureteral stents were cystoscopically placed in seven (35%)
of the 20 patients with ureteral involvement; the others
underwent surgical ureterolysis (as did three of the patients
who initially received ureteral stents).
Twenty-two (92%) patients were followed up for a median
of 54 months (range 9–197), and are still alive; the remaining
two (8%) were lost to follow-up after 2 and 27 months,
respectively. During the follow-up, none of the patients
developed cancer or major infectious diseases.
Radiologic findings
Imaging studies were available for review in all of the 24
patients. CT/MRI scans showed that IRF surrounded the
abdominal aorta in 22 (92%) patients (Figure 1a), in most of
whom it also involved the iliac vessels; the perivascular tissue
usually ranged from the origin of the renal arteries up to the
bifurcation of the common iliac arteries. Six patients also
showed pericaval distribution, and one peripancreatic and
perisplenic involvement. The retroperitoneal mass in one
patient almost exclusively encircled the left common iliac
artery (Figure 1b) and spared the surrounding soft tissues; in
another, it had a bilateral periiliac localization with presacral
extension. Finally, in two patients, IRF was associated with
mediastinal fibrosis, which involved the soft tissues sur-
rounding the mediastinal portion of the thoracic aorta
(Figure 1c).
The transverse and antero-posterior diameters of the
retroperitoneal masses – measured on CT scan with the
subtraction of the aortic breadth – averaged 3.371.2 cm
(range 1.8–5) and 1.870.6 cm (range 1–2.7), respectively.
Two patients (nos. 10 and 17) underwent imaging studies
of the renal arteries: patient no. 10 was diagnosed as having
right renal artery stenosis by means of angiography, whereas
patient no. 17 was diagnosed with left renal artery stenosis by
means of angio-MRI. Only patient no. 17 had clinical
evidence of renovascular hypertension.
The analysis of aorto-iliac vascular calcifications on non-
contrast-enhanced CT scans yielded the following results: 7/20
patients (35%) had no calcifications (grade 0), 8/20 (40%)
had an average of grade 1þ , 3/20 (15%) grade 2þ , and 2/20
(10%) grade 3þ . Calcifications were more prominent at the
lower abdominal aortic and iliac than at the upper abdominal
aortic levels.
Finally, four patients (nos. 3, 12, 16, and 20) showed
aneurysmal dilatation of the abdominal aorta.
Gross findings
Intraoperatively, IRF always presented as firm grayish masses.
The specimens taken from the peripheral areas of the mass
showed a combination of grayish and yellow zones suggesting
infiltration in the retroperitoneal adipose tissue; none of
them had a fibrous capsule.
Microscopic findings
All of the examined specimens consisted of fibrous tissue and
inflammatory infiltrate (Figure 2a).
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Table 1 | Clinical and laboratory findings of the 24 patients with IRF
Patient
no.
Age
(years)/
sex
RPF
localization
Clinical symptoms
and signs
Ureteral
involvement
Baseline
creatinine
(mg/dl), Dt*
Presenting
creatinine
(mg/dl)
Acute
renal
failure
ESRrate
(mm/h)
CRP
(mg/l) ANA
Other positive
autoantibodies
Associated
autoimmune
diseases
1 68/F Periaortic,
periiliac
Abdominal pain,
constipation,
constitutional
symptoms, urinary
tract infection
Bilateral
hydronephrosis
NA 3.5 Yes 102 52 1/80 Anti-TG,
anti-TPO,
anti-smooth
muscle
Chronic
autoimmune
thyroiditis
2 51/M Periaortic,
periiliac
Back and perineal
pain, left hydrocele
and varicocele,
constitutional
symptoms
Bilateral
hydronephrosis
NA 1.1 No 48 41 Negative Reactive
arthritis
3 62/M Periaortic Abdominal, gluteal
and testicular pain,
hydrocele
Unilateral
hydronephrosis
NA 1.4 No 43 ND 1/320
4 47/M Periaortic,
periiliac
Back and testicular
pain, varicocele
Bilateral
hydronephrosis
NA 1.4 No 35 5 Negative Anti-smooth
muscle
5 55/F Periaortic,
pericaval
Ureteral colic pain, leg
claudicatio, hydrocele
and varicocele,
constitutional
symptoms
Bilateral
hydronephrosis
0.8 (12
months)
1.4 Yes 10 20 Negative
6 60/M Periaortic,
pericaval
Back pain, constitu-
tional symptoms
Bilateral
hydronephrosis
NA 7.0 Yes 40 11 Negative Anti-TG,
anti-TPO
Acute
autoimmune
thyroiditis
7 30/M Periiliac, left
iliac fossa
Back pain, hydrocele,
varicocele, left thigh
edema
Unilateral
hydronephrosis
NA 0.6 No 124 50 1/80 Anti-smooth
muscle,
P-ANCAw
8 38/M Periaortic,
periiliac
Abdominal pain, deep
vein thrombosis of the
lower limbs,
constitutional
symptoms, urinary
tract infection
Bilateral
hydronephrosis
1.4 (12
months)
8.1 Yes 97 105 Negative Anti-smooth
muscle
9 55/M Periaortic,
periiliac
Ureteral colic pain, leg
claudicatio, hydrocele
and varicocele,
constitutional
symptoms
Bilateral
hydronephrosis
NA 1.1 No 71 41 1/80 Anti-TG,
anti-TPO
Chronic
autoimmune
thyroiditis
10 53/M Periaortic,
periiliac,
pericaval
Abdominal and back
pain, hydrocele,
varicocele,
constitutional
symptoms
Unilateral
hydronephrosis
NA 0.9 No 98 ND Negative Anti-TG,
anti-TPO,
rheumatoid
factor
Chronic
autoimmune
thyroiditis
11 60/M Periaortic,
periiliac
Back pain, deep vein
thrombosis of the
lower limbs
Bilateral
hydronephrosis
NA 8.3 Yes 120 50 1/320
12 61/M Periaortic,
periiliac
Abdominal, testicular
and back pain,
constipation, erectile
failure, hydrocele and
varicocele,
constitutional
symptoms
Absent NA 0.8 No 99 20 Negative
13 54/M Periaortic,
periiliac
Abdominal, testicular
and back pain,
constipation,
constitutional
symptoms
Unilateral
hydronephrosis
NA 1.0 No 91 26 Negative
14 64/F Periaortic,
periiliac
Abdominal and back
pain, pollakiuria,
constitutional
symptoms
Bilateral
hydronephrosis
NA 8.1 Yes 100 182 1/320
15 49/M Periaortic,
periiliac
Abdominal and back
pain, leg claudicatio,
hydrocele and
varicocele,
constitutional
symptoms
Absent NA 0.8 No 15 4 Negative
16 75/M Periaortic,
periiliac
Back pain, leg
claudicatio,
constitutional
symptoms
Bilateral
hydronephrosis
1.1 (10
months)
2.1 Yes 40 26 1/80 Rheumatoid
factor
Rheumatoid
arthritis
Table 1 continued on the following page
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The fibrous component was characterized by mild-to-
moderate spindle-shaped cell proliferation, with varying
amounts of extracellular collagen. These cells were med-
ium-sized with elongated normochromatic nuclei; they were
closely associated with bands of collagen varying from thin
deposits in the more cellular areas to densely hypocellular
collagenous tissue with a keloid-like appearance (Figures 2b
and c). The interface between IRF and the preexisting adipose
tissue was poorly demarcated. Mitoses were exceedingly rare.
There were no signs of necrosis, whereas rare hemorrhage
microfoci were found in some cases. The collagenous stroma
contained varying quantities of small blood vessels, which
often showed prominent perivascular hyalinization (Figure
2d). In addition, some nerves were entrapped in the fibrous
proliferation (Figure 2e). There were no calcifications or
areas of bone or cartilagineous metaplasia. Congo red and
Weigert staining did not reveal any amyloid or elastic fibres
(except in the vascular walls).
The fibrous background contained various degrees of
inflammatory infiltrate consisting of small lymphocytes,
macrophages, plasma cells and rare eosinophils, and
characterized by two main patterns: perivascular and diffuse.
The perivascular pattern principally consisted of lymphocytes
aggregated within and around the adventitia of the small
blood vessels; in 11 (46%) cases, some vessel walls were
infiltrated and sometimes necrotic, thus suggesting an
ongoing vasculitic process (Figure 2f). The diffuse pattern
was characterized by looser aggregates of lymphocytes,
macrophages, and rare eosinophils infiltrating the narrow
spaces between the collagen bands. Table 2 shows a
semiquantitative evaluation of the intensity of the inflam-
matory patterns and the presence of a vasculitic process.
Immunohistochemical findings
The spindle-shaped cells were globally stained with vimentin
(Figure 3a) and, in the more cellular areas, smooth muscle
actin primary antibodies (Figure 3b), but did not express
cytokeratin pool, caldesmon, S100, CD34, CD117, ALK-1,
b-catenin, desmin, myogenin, or myoglobin. In addition, the
Ki67 proliferation index in these cells was always negligible.
The bands of fibrous tissue were diffusely stained with an
anti-type-I collagen antibody (Figure 3c).
The inflammatory infiltrate included small T (CD3þ ,
either CD4þ or CD8þ ) and B (CD20þ ) lymphocytes
(Figure 4), macrophages, plasma cells (CD138þ ), and
scattered eosinophils. The inflammatory elements were
always negative for human granzyme B. The proportions of
the different lymphoid subsets in the perivascular and diffuse
areas are shown in Table 3.
Most of the perivascular inflammatory infiltrates
had a peculiar target-like appearance, with the central
portion occupied by CD20þ lymphocytes, and the periph-
ery mainly consisting of CD4þ and CD8þ lymphocytes
(Figure 4).
Table 1 | Continued
Patient
no.
Age
(years)/
sex
RPF
localization
Clinical symptoms
and signs
Ureteral
involvement
Baseline
creatinine
(mg/dl), Dt*
Presenting
creatinine
(mg/dl)
Acute
renal
failure
ESRrate
(mm/h)
CRP
(mg/l) ANA
Other positive
autoantibodies
Associated
autoimmune
diseases
17 37/M Periaortic,
periiliac
Hydrocele and
varicocele, reno-
vascular hypertension
Bilateral
hydronephrosis
NA 2.1 Yes 90 15 Negative Anti-TG,
anti-TPO
Chronic
autoimmune
thyroiditis
18 53/F Periaortic,
periiliac,
peripancreatic,
perisplenic
Constitutional
symptoms
Bilateral
hydro-
nephrosis
NA 2.8 Yes 63 24 1/320
19 40/M Periaortic,
pericaval
Ureteral colic pain,
constitutional
symptoms
Bilateral
hydronephrosis
NA 12.0 Yes 70 25 ND
20 69/M Periaortic,
periiliac,
pericaval
Sciatalgia, pollakiuria,
right varicocele,
constitutional
symptoms
Bilateral
hydronephrosis
NA 7.0 Yes 91 27 Negative Anti-smooth
muscle
21 59/F Periaortic,
periiliac
Ureteral colic pain,
constitutional
symptoms
Bilateral
hydronephrosis
0.8 (2
months)
4.2 Yes 110 30 Negative
22 59/F Periaortic Abdominal and back
pain, constitutional
symptoms
Absent NA 0.9 No 53 1.9 Negative
23 56/F Periaortic,
pericaval
Ureteral colic pain,
constitutional
symptoms
Bilateral
hydronephrosis
0.9 (3
months)
5.6 Yes 96 75 1/80 Anti-TPO,
anti-Ro
Chronic
autoimmune
thyroiditis
24 77/F Periiliac Abdominal pain,
constitutional
symptoms
Absent NA 0.9 No 95 26 1/80 Anti-smooth
muscle
ANA, antinuclear antibody; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; NA, not available; ND, not determined; P-ANCA, perinuclear antineutrophil
cytoplasmic antibody; RPF, retroperitoneal fibrosis; TG, thyroglobulin; TPO, thyroperoxidase.
CRP, normal o5 mg/l; constitutional symptoms include: fatigue, anorexia, weight loss, low-grade fever, diffuse arthralgias, and myalgias.
wP-ANCA (titer 1/40) were anti-myeloperoxidase antibodies (20 EU/ml, normal o5); Dt*: time interval between baseline and presenting creatinine.
Kidney International (2007) 72, 742–753 745
D Corradi et al.: Histopathology of idiopathic retroperitoneal fibrosis o r i g i n a l a r t i c l e
A large fraction of CD138-positive plasma cells (92.57
4.3%) showed concomitant IgG4 immunoreactivity (Figure 5).
There were no quantitative differences in evaluating the
fraction of IgG4 plasma cells in histological fields character-
ized by either perivascular or diffuse inflammatory infiltrate
patterns.
Ultrastructural findings
The ultrastructural analysis confirmed the light microscopy
findings. Fibroblasts, sometimes with the features of
myofibroblasts, were located in abundant collagen in
association with a polymorphic inflammatory infiltrate
(Figure 6a). In particular, they appeared as spindle-shaped
elements with regular cell contours, characterized by a
narrow oval-long nucleus with regularly distributed chroma-
tin and, sometimes, a nucleolus; there was also a well-
developed Golgi zone, a rough endoplasmic reticulum, and
mitochondria. The myofibroblasts were often irregularly star-
shaped, sometimes with thin cytoplasmic projections pro-
truding into the extracellular space.
The stromal part was characterized by thick fascicles of
single collagen fibres irregularly distributed along the lesion.
Interestingly, a frequent finding was the presence of a regular
circumferential bundle of collagen surrounding blood vessels
(Figure 6b) and nerves. High magnification revealed that
these fibres consisted of a number of thinner thread-like
fibrils (B50 nm in diameter), which were characterized by
light and dark cross-striation with a periodicity of B45 nm
(Figures 6c and d).
Clinico-pathologic correlations
No correlations were found between the clinico-laboratory
findings, namely ESR, CRP levels, autoantibody positivity
and constitutional symptoms, and the intensity of the
a
b
c
Figure 1 | Computed tomography findings in idiopathic
retroperitoneal fibrosis. (a) The scans show a retroperitoneal mass
(arrow) of soft tissue characterized by a density similar to that of
skeletal muscle, surrounding the abdominal aorta, a finding typical of
IRF. Bilateral hydronephrosis can also be observed. (b) Atypical
localization of IRF: CT scan shows that the perivascular fibrous tissue
(arrow) mainly surrounds the left common iliac artery; in this patient,
the periaortic space was not affected. (c) Mediastinal fibrosis in a
patient with IRF. CT scan shows fibrous involvement (arrow) of the
soft tissues surrounding the mediastinal portion of the thoracic aorta.
a b
c d
e f
Figure 2 | Histopathological appearance of idiopathic
retroperitoneal fibrosis. (a) Architecture of IRF. Fibro-inflammatory
proliferation infiltrates the retroperitoneal soft tissues with a
perivascular (arrowhead) or diffuse pattern (arrow). Only a few
residual adipocytes are still detectable. Hematoxylin and eosin;
original magnification:  4; bar¼ 400mm. (b) Loose deposition of
collagen matrix organized in thick irregular bands. Hematoxylin and
eosin; original magnification:  10; bar¼ 150 mm. (c) Collagen
deposition with a denser arrangement of collagen bands than in
panel b. Hematoxylin and eosin; original magnification:  10;
bar¼ 150 mm. (d) A frequent finding in retroperitoneal fibrosis is a
peripheral bundle of collagen fibers (arrows) surrounding the
adventitia of small retroperitoneal blood vessels. Hematoxylin and
eosin; original magnification:  20; bar¼ 100mm. (e) A nerve (arrow)
is entrapped within the fibro-inflammatory proliferation. Hematoxylin
and eosin; original magnification:  20; bar¼ 100mm. (f) Transmural
inflammatory infiltration of a retroperitoneal small blood vessel.
Hematoxylin and eosin; original magnification:  20; bar¼ 100 mm.
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inflammatory infiltrate or the prevalence of the different
immunostained cells.
ESR was higher in patients with (median 91 mm/Ih, range
40–120) than in patients without (median 30 mm/Ih, range
11–105) signs of vasculitis on retroperitoneal biopsy; this
difference, however, did not reach the level of statistical
significance (P¼ 0.14). No association was found between
the histological evidence of vasculitis and the presence of
acute renal failure or the positivity of antinuclear antibody,
anti-neutrophil cytoplasmic antibody, anti-smooth muscle,
anti-thyroid antibodies, and rheumatoid factor.
DISCUSSION
IRF is a rare disease that usually presents as a fibrous
periaortic mass obstructing the adjacent abdominal struc-
tures (e.g., ureters and inferior vena cava) and causing
varying degrees of renal insufficiency. Its etiopathogenesis is
Table 2 | Inflamatory patterns and vasculitis
Patient
No.
Perivascular
inflammatory
infiltrate grading
Diffuse
inflammatory
infiltrate
grading
Vasculitis of
small
retroperitoneal
vessels
1 ++ + Yes
2 ++ +++ Yes
3 ++ + No
4 ++ ++ No
5 + ++ No
6 ++ +++ Yes
7 + + No
8 ++ +++ Yes
9 ++ +++ Yes
10 ++ ++ No
11 ++ + Yes
12 + ++ Yes
13 ++ +++ Yes
14 ++ ++ No
15 + + No
16 + + No
17 + + No
18 ++ +++ Yes
19 ++ +++ Yes
20 + + No
21 ++ +++ Yes
22 ++ ++ No
23 ++ ++ No
24 + + No
Inflammatory infiltrate grading: +=mild, ++=moderate, +++=severe (see text).
a b
c
Figure 3 | Immunohistochemistry with anti-vimentin,
anti-smooth muscle actin, and anti-type-I collagen antibodies.
The spindle-shaped elements show constant positivity for (a)
vimentin, but are also reactive for (b) smooth muscle actin in the
more cellular areas. Fibrous bands that surround tissue areas
characterized by a wide inflammatory infiltrate, show diffuse
positivity for (c) type-I collagen. Mayer hematoxylin counterstained;
original magnifications: (a) and (b):  10, bar¼ 150mm; (c):  4,
bar¼ 400 mm.
a b
c d
e f
g h
Figure 4 | Lymphocyte subsets in the perivascular and diffuse
inflammatory infiltrates. (a) CD3þ and (b) CD20þ lymphocytes
are the main components of the perivascular inflammatory infiltrate.
There are more (c) CD4þ than (d) CD8þ T lymphocytes. A frequent
finding in the perivascular aggregates is a target-like appearance with
(b) a central part of B lymphocytes and (a) a periphery of T
lymphocytes. In the diffuse inflammatory infiltrate, (e) CD3þ
lymphocytes are the major subset, whereas (f) CD20þ cells are a
minor component, and the (g) proportions of CD4þ and (h) CD8þ
T lymphocytes are similar. Mayer hematoxylin counterstained;
original magnification:  10; bar¼ 150 mm.
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unclear. Some Authors proposed that it can be the result of
an exuberant reaction to antigens in the atherosclerotic
plaques of the abdominal aorta, but it can also be considered
the manifestation of a systemic autoimmune disease, because
IRF patients often show constitutional symptoms, high
acute-phase reactants, positive autoantibodies and associated
autoimmune conditions (e.g., thyroiditis and systemic
vasculitis); in addition, IRF is significantly associated with
HLA-DRB1*03, an allele linked to a wide range of
autoimmune diseases including type I diabetes mellitus and
systemic lupus erythematosus.16
CT and MRI are thought to be the examinations of choice
in the diagnosis of IRF.4 Advantages of MRI include the
avoidance of contrast, which can be particularly useful in
patients with impaired renal function; however, as a number
of reports have recently described the so-called ‘nephrogenic
systemic fibrosis’ (a scleroderma-like dermopathy with
possible involvement of other organ systems) in patients
with renal failure who underwent gadolinium-enhanced
MRI,17 caution should be observed against this imaging
technique particularly in IRF patients with renal function
impairment.
Because a fibrosing retroperitoneal process may also be
secondary to a wide spectrum of causes such as tumors (e.g.,
lymphoma and sarcoma) and infections (e.g., tuberculosis),
whose clinical and radiological manifestations may mimic
those of the idiopathic form, the diagnosis of IRF is often
quite challenging. CT/MRI findings such as an anterior
displacement of the aorto-iliac vessels by the mass or an
inhomogeneous signal in T2-weighted MRI images18 should
heighten suspicion of a secondary form. However, in a
number of cases the histopathological examination of the
retroperitoneal tissue is mandatory. These include the
presence of clinical or radiological signs suggesting an
underlying malignancy, atypical localization of the mass
(e.g., pelvic, perirenal, and isolated periiliac; see Figure 1b),
and also limited experience with the diagnosis and clinical
management of such a rare condition. In addition, because
IRF usually responds to steroids and/or immunosuppres-
Table 3 | Proportions of the different lymphoid subsets
Inflammatory pattern CD3 CD20 CD4 CD8
Perivascular (%) 46.0715.0 (21.8–64.1) 54.0715.0 (35.9–78.2) 74.9714.7w (33.6–91.1) 25.1714.7 (8.9–66.4)
Diffuse (%) 74.779.2* (56.8–85.5) 25.379.2 (14.5–43.2) 51.1715.9 (14.3–67.4) 48.9715.9 (32.6–85.7)
Statistical results. *=Po0.0001 compared with corresponding CD20, w=Po0.0001 compared with corresponding CD8. Mean values7s.d. (with ranges in parenthesis).
a
b
c
Figure 5 | IgG4-positive plasma cells. The inflammatory
infiltrate contains varying amounts of (a) CD138þ plasma cells.
(b) Two plasma cells identified by immunofluorescence with a
rhodamine-labeled anti-CD138 primary antibody. (c) The same
microscopic field after incubation with a fluorescein-conjugated
anti-IgG4 primary antibody. Only one plasma cell expresses this
IgG isotype. (a) Mayer hematoxylin counterstained; original
magnification:  10; bar¼ 150 mm. (b and c) Original
magnification:  40; bar¼ 40 mm.
a b
c d
Figure 6 | Ultrastructural appearance of idiopathic
retroperitoneal fibrosis. (a) A stellate myofibroblast is located
within a matrix consisting of irregularly oriented collagen fibrils
(arrow). Original magnification:  3500; bar¼ 7 mm. (b) A small blood
vessel (asterisk) is surrounded by a thick band of collagen fibrils
(arrow). Original magnification:  3500; bar¼ 7 mm. (c) A bundle of
collagen consisting of several thread-like fibrils. Original
magnification:  7100; bar¼ 3 mm. (d) Detail of panel C showing the
light and dark cross-striation of the fibrils. Original magnification:
 71 000; bar¼ 300 nm.
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sants, a retroperitoneal biopsy should be considered in case of
a lack of response.
The purpose of our study was to define, in a large series of
patients, the morphological and immunohistochemical
characteristics of IRF to be able to better differentiate this
disorder from other retroperitoneal diseases having a similar
appearance.
The results of our histological and immunohistochemical
analyses confirmed that IRF is a fibro-inflammatory process
characterized by spindle-shaped cells mixed with varying
amounts of inflammatory infiltrate. The fibroblastic/myo-
fibroblastic origin of the spindle-shaped cells was supported
by their diffuse expression of vimentin and smooth muscle
actin. Moreover, their ultrastructural features were also in
line with such an origin. There were no signs of active
fibroblast proliferation.
The inflammatory infiltrate mainly consisted of lympho-
cytes and macrophages, with scattered plasma cells and
eosinophils, and was characterized by two main patterns:
diffuse and perivascular. In the former, the cells diffusely
infiltrated the lesion without any particular target. The
perivascular pattern was observable at low-power magnifica-
tion as cellular aggregates mainly consisting of lymphocytes
localized around small blood vessels. Perivascular aggregates
often showed a unique target-like appearance, with a central
core of B cells surrounded by a mantle of T cells.
Interestingly, the great majority of the infiltrating plasma
cells expressed the IgG4 isotype, which would physiologically
represent the rarest IgG subclass. Over the past few years, a
close association between IgG4 and sclerosing processes –
including retroperitoneal and mediastinal fibroses, sclerosing
cholangitis, sialoadenitis, and pancreatitis – has been
demonstrated.19–22 In addition, about half of the examined
specimens also showed focal but clear signs of vasculitis
affecting small-to medium-sized retroperitoneal vessels. This
is consistent with previous findings5,8,11,23,24 and raises the
question whether a vasculitic process is involved in the
development of IRF.5
The above findings may help differentiate between IRF
and other retroperitoneal fibro-inflammatory disorders
(Table 4). The presence of a frequently chronic inflammatory
infiltrate in a sclerotic background can be seen in both benign
and malignant soft tissue lesions.
The major entity to be ruled out is a lymphoproliferative
disorder with nodular lymphocyte pattern and/or sclerosis.
The retroperitoneum is rich in lymphoid tissue and is thus
amenable to involvement by a variety of lymphoid prolifera-
tions, particularly follicular lymphoma and classical Hodgkin
lymphoma. In particular, follicular lymphoma, in addition to
the predominant follicular distribution of the neoplastic cells,
may display areas characterized by a diffuse pattern often
associated with varying narrow strands of non-compartmenta-
lizing fibrous bands with entrapped neoplastic B cells.30 At the
same time, nodular sclerosis Hodgkin lymphoma may also
mimic IRF. The fibrotic host response characteristic of classical
Hodgkin lymphoma, nodular sclerosis type, may resemble IRF.
Classical Hodgkin lymphoma can show broad, paucicellular
compartmentalizing fibrotic bands, which efface the tissue
architecture. However, in contrast to IRF, classical Hodgkin
lymphoma is characterized by dense cellular nodules consist-
ing of lymphocytes, granulocytes, and histiocytes admixed
with diagnostic Hodgkin Reed–Sternberg cells, whose presence
allows exclusion of IRF.31 Additionally, a mixed inflammatory
infiltrate – featuring both T and B lymphocytes, plasma cells,
eosinophils, and histiocytes – without any signs of cellular
atypia, usually steers the diagnosis toward a reactive
inflammatory process. Polymerase chain reaction-based ana-
lyses may be helpful in dubious cases.56–58
Other rare diseases with similar histological features must
be considered in the differential diagnosis of IRF. Idiopathic
retractile mesenteritis, characterized by fat necrosis, lipid-
laden macrophages, and calcifications, involves the mesentery
and lacks the typical periaortic disposition.36 In the scar-like
(or desmoid) variant of the inflammatory myofibroblastic
tumor, the spindle-shaped cell component stains for
vimentin, variably for smooth muscle and muscle-specific
actin, and for desmin in many cases; approximately one-third
of the cases are positive for cytokeratin and half of them for
ALK-1. Desmin, cytokeratin, and ALK-1 were all consistently
negative in IRF. Desmoid fibromatosis, in opposition to IRF,
shows fibroblastic/myofibroblastic proliferation in dense
collagen tissue, usually without any remarkable chronic
inflammatory infiltrate, and nuclear positivity for b-cate-
nin,39 which was negative as well in IRF. Well-differentiated
liposarcomas with sclerosing and inflammatory features can
be distinguished from IRF by means of a careful search for
lipoblasts.52 Finally, unlike IRF, retroperitoneal xanthogra-
nulomatosis (isolated or associated with Erdheim–Chester
disease) is characterized by varying amounts of ‘foamy’
histiocytes (consistently negative for CD1a) in dense collagen
tissue.48
In conclusion, IRF is a rare fibrosing disorder that usually
affects periaortic and periiliac retroperitoneal soft tissues. In
addition to clinical, laboratory, and imaging findings,
histological evaluation of a retroperitoneal biopsy may be a
crucial step in its diagnosis. A collagen-rich background with
fibroblastic/myofibroblastic elements lacking signs of atypia,
mitotic figures, or morphological or immunohistochemical
features of other fibrous proliferations, along with a diffuse
and perivascular inflammatory infiltrate mainly consisting of
T and B lymphocytes (but also including macrophages, IgG4-
positive plasma cells, and eosinophils) may be considered the
histopathological portrait of IRF.
MATERIALS AND METHODS
Twenty-four consecutive patients with IRF were enrolled by the
Department of Clinical Medicine and Nephrology of Parma
University Hospital (20 patients) and the Division of Nephrology
of the Policlinico Hospital in Milan (four patients) between June
1997 and July 2004; 12 patients were diagnosed in and 12 were
referred to these two centers from other Italian hospitals. The study
was conducted in accordance with a protocol approved by our
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Institutional Human Research Committee and respected the
principles outlined in the Declaration of Helsinki.
Some of the patients included in this study were also the subjects
of other studies conducted by our group: seven (nos. 1, 2, 4, 11, 15,
17, and 24), one (no. 14) and two patients (nos. 9 and 17),
respectively, in three papers by Vaglio et al.5,59,60 and three (nos. 5, 6,
and 18) in two investigations by Moroni et al.15,61
The inclusion criteria were a clinical and CT/MRI diagnosis of
IRF, and the availability of multiple biopsies of the retroperitoneal
mass. IRF was defined by CT or MRI as a retroperitoneal mass of
soft-tissue density surrounding the abdominal aorta and/or iliac
arteries (but with possible involvement of other structures such as
the inferior vena cava, the pancreas, and the spleen), with
homogeneous attenuation and not causing aortic displacement or
bone destruction.9
We excluded cases of retroperitoneal fibrosis that were secon-
dary to the following etiologies: drugs (e.g., ergotamine and
methysergide), infections (e.g., tuberculosis and syphilis), cancer
(e.g., sarcoma and lymphoma), major abdominal surgery, trauma,
radiotherapy, and systemic connective tissue or vasculitis diseases
(e.g., systemic lupus erythematosus and Wegener’s granulomatosis).
The patients’ medical history was reviewed, and all of them
underwent physical examination, routine laboratory tests including
the measurement of ESR, CRP levels, autoantibodies (anti-nuclear,
anti-extractable nuclear antigen, anti-dsDNA and anti-smooth
muscle antibodies, anti-neutrophil cytoplasmic antibodies, rheuma-
toid factor, cryoglobulins, anti-thyroid microsome, and anti-
thyroglobulin antibodies), and C3 and C4 complement fractions,
as described previously.5 They also underwent chest radiography,
thyroid echotomography, and abdominal CT or MRI scans.
Acute renal failure was defined as a rapid increase of more than
50% in serum creatinine or 41 mg/dl increase in serum creatinine
with known renal insufficiency, where baseline creatinine levels were
available.62 If baseline creatinine was not available, it was defined as
an impairment in renal function (serum creatinine 41.4 mg/dl),
which proved to be reversible within days to weeks after correction
of obstructive uropathy (e.g., by ureteral stents).
Hydronephrosis was defined as an abnormal enlargement or
swelling of a kidney due to dilation of the kidney calices and the
kidney pelvis.
To explore the prevalence and extent of vascular calcifications as a
marker of atherosclerosis, an independent radiologist reviewed the
Table 4 | Differential diagnosis between IRF and other retroperitoneal fibrosing/inflammatory disorders: imaging,
histopathological, and main immunohistochemical findings
Idiopathic
retroperitoneal
fibrosis9,25
Retroperitoneal
lymphoma26–32
Sclerosing
mesenteritis33–37
Desmoid-type
fibromatosis38–41
Inflammatory
myofibroblastic
tumour38,42–45
Erdheim–Chester
disease46–50
Well-
differentiated
liposarcoma,
sclerosing
variant51–55
CT/MRI findings Periaortic and/or
periiliac
homogeneous
soft-tissue mass;
non-infiltrative;
frequent medial
ureteral
deviation; rare
aortic
displacement
Usually
inhomogeneous
retroperitoneal
mass; may cause
anterior aortic
and lateral
ureteral
displacement
and bone
invasion
Soft-tissue mass
involving the
small bowel
mesentery; small
bowel kinking/
fixation; frequent
calcifications
Intraabdominal
soft-tissue mass,
often with mass
effect; variable
location;
frequently
associated with
Gardner’s
syndrome
Infiltrative or,
rarely, well-
defined soft-
tissue mass;
variable location;
heterogeneous
attenuation
Soft-tissue mass
surrounding
aorta, iliac
arteries, and
kidneys
Usually, large
retroperitoneal
mass; variable
location;
heterogeneous
MRI intensity,
depending on
the histological
components of
the tumour
Ureteral
obstruction
About 80% Up to 50% Rare Rare Rare About 20% Unknown
Reactive
perivascular
lymphoid
aggregates
100% Absent Variable Unusual Variable Negative Possible in the
inflammatory
variant
Necrosis Absent Variable Frequent fat
necrosis
Unusual Sometimes focal Absent Fat necrosis in
larger lesions
Vasculitis About 50% Absent Absent Absent Absent Absent Absent
Mitotic activity Very low or
absent
Variable Usually scanty or
absent
Usually scanty or
absent
Variable Very low Variable
Clonality Absent Variable Absent Absent Absent Usually absent Present
b-Catenin Negative Unknown Negative About 90% Negative Negative Variable
cytoplasmic
positivity
ALK-1 Negative Usually absent Negative Negative About 50% Negative Negative
CD117 (c-kit) Negative in the
spindle cell
component
Rare Variable Negative Rare Negative Negative
Desmin Negative Negative Variable Rare Frequently
positive
Negative Rare
S100 Negative Negative Negative Rare Negative Variable Usually positive
in the adipocytic
component
CT, computed tomography; IRF, idiopathic retroperitoneal fibrosis; MRI, magnetic resonance imaging.
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non-contrast-enhanced abdominal CT scans of the 20 patients who
were studied by means of CT. In each case, three levels were chosen
(1: abdominal aorta, just below the origin of the renal arteries; 2: just
above the aorto-iliac bifurcation; 3: mid-portion of the common iliac
arteries) and vascular calcifications were assessed using a four-point
semiquantitative scale (0: no calcifications; 1þ : calcifications invol-
ving up to one-third of the vascular circumference; 2þ : calcifications
involving one-third to two-third of the vascular circumference; 3þ :
calcifications involving more than two-third of the vascular circum-
ference). Average of the three levels was then calculated.
The retroperitoneal samples were obtained during laparotomy
for ureterolysis in 16 patients (67%), explorative laparotomy in five
(21%), and explorative laparoscopy in three (12%).
Histological evaluation
After excision, the retroperitoneal samples were fixed in a 10%
buffered formalin solution for 24 h, and then embedded in paraffin
tissue blocks from which 5 mm-thick histological sections were
obtained for histological and immunohistochemical analyses. The
slides were stained with hematoxylin and eosin, the Van Gieson
method for collagen, Congo Red, periodic acid-Schiff, and the
Weigert technique for elastic fibres. Their mitotic index was assessed
by observing the whole histological hematoxylin and eosin-stained
section. In each case, the perivascular and diffuse inflammatory
infiltrates were semiquantitatively graded by calculating the density
of the perivascular aggregates as well as that of the flogistic elements
that constituted the diffuse pattern. In particular, we considered as
mild (þ ), moderate (þ þ ), and severe (þ þ þ ) the perivascular
patterns showing, respectively, less than 10, between 10 and 20, and
more than 20 perivascular aggregates per cm2 of lesion, and the
diffuse patterns constituted of, respectively, an average value of less
than 40, between 40 and 60, and more than 60 flogistic elements
(lymphocytes, plasma cells, granulocytes, and histiocytes) per
microscopic field observed at a magnification of  1000
(0.04 mm2). These evaluations were performed on hematoxylin
and eosin-stained sections. The perivascular infiltrate was quantified
by counting the total number of perivascular aggregates and then
dividing that value by the whole tissue area observed (measured
using the Image-Pro Plus 4.5 software, Media Cybernetics, Silver
Spring, MD). The diffuse inflammatory infiltrate was measured by
counting the average number of inflammatory elements per
microscopic field after evaluating 30 histological fields (total square
area examined 1.2 mm2) in each case.
Immunohistochemistry
The fibrous and inflammatory components were immunohisto-
chemically studied using the manufacturers’ protocols and routine
primary antibodies. Some of the antibodies used for the immuno-
histochemical examination were chosen on the basis of their positive
staining in other fibro-inflammatory conditions that are considered
in the differential diagnosis of IRF. The primary antibodies, their
dilutions, pretreatments, and commercial sources are listed in Table 5.
Morphometric analysis of the IgG4-positive plasma cells and
the lymphoid component
A morphometric analysis was carried out to measure the percentages
of the different lymphocyte subsets and the IgG4-positive plasma
cells.
The lymphocyte subsets were quantitatively evaluated on
histological sections stained with primary antibodies against CD3,
CD4, CD8, and CD20. The lymphoid components were morpho-
metrically sampled using a light microscope (Olympus BX 51,
Tokyo, Japan) at a magnification of  1000 by counting the total
number of immunostained cells within a microscopic field
(0.04 mm2). Thirty fields from each sample were measured, thus
leading to an observed total tissue area of 1.2 mm2. The percentages
of the different lymphocyte subsets were calculated by dividing the
number of each cell type by the total number of immunostained
cells, and multiplying that value by 100.
In each case, the fraction of IgG4-positive plasma cells was
measured on the same histological section that had been stained
Table 5 | Primary antibodies
Antibody Clonality Clone Source Reference Dilution Pretreatment Incubation (min)
CD3 M PS-1 Novocastra NCC-CD3-PS1 1:100 mw EDTA 30 rt
CD4 M OPD4 DakoCytomation MO 834 1:100 mw cit 30 rt
CD8 M C8/144B NeoMarkers MS-457-R7 1:50 mw cit 30 rt
CD20cy M L26 DakoCytomation M0755 1:50 mw cit 30 rt
CD34 M QBEnd/10 NeoMarkers MS-363-P0 1:50 mw cit 30 rt
CD68 M PG-M1 DakoCytomation M0876 1:50 pd 30 rt
CD117 (c-kit) P DakoCytomation A4502 1:100 no 30 rt
CD138 (syndecan-1) M 5S7 Novocastra NCL-CD138 1:50 mw EDTA on 41C
CD246 (ALK protein) M ALK1 DakoCytomation M7195 1:50 mw cit 30 rt
IgG4 M HP6025 ZYMED Laboratories 05-3800 1:50 mw EDTA on 41C
Collagen I M I-8H5 Calbiochem CP17L 1:100 mw cit 30 rt
Human caldesmon M h-CD DakoCytomation M3557 1:50 mw cit 30 rt
Smooth muscle actin M 1A4 NeoMarkers MS-113-P 1:200 no 30 rt
Human granzyme B M GrB-7 DakoCytomation M7235 1:50 no 30 rt
Vimentin M V9 NeoMarkers MS-129-P1 1:500 no 30 rt
S100 M 15E2E2 Biogelex MU-058-UC 1:800 no 30 rt
b-Catenin M b-Catenin 1 DakoCytomation M3539 1:200 mw cit 30 rt
Ki67 M MIB-1 DakoCytomation M7240 1:100 mw cit 30 rt
Cytokeratin pool M AE1/AE3 DakoCytomation M3515 1:100 mw cit 30 rt
Desmin M D33 DakoCytomation M0760 1:100 no 30 rt
Myogenin M F5D NeoMarkers MS-III3-P1 1:100 mw cit 30 rt
Myoglobin P DakoCytomation AO324 1:150 no 30 rt
rt, room temperature; cit, citrate buffer; EDTA, ethylenediaminetetraacetic acid buffer; M, monoclonal; mw, microwave; on, overnight; P, polyclonal; pd, proteinase digestion.
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with primary antibodies against CD138 and IgG4. These reactions
were revealed using the two fluorescent probes tetramethylrhoda-
mine goat anti-mouse IgG secondary antibody for CD138 (dilution
1:100, Molecular Probes, Eugene, OR) and fluorescein isothiocya-
nate-conjugated goat anti-mouse IgG secondary antibody for IgG4
(dilution 1:100, Chemicon, Temecula, CA).
The morphometric evaluation of IgG4-positive plasma cells was
performed by fluorescent microscopy (Olympus BX60F5, Tokyo,
Japan) at a magnification of  1000. Within each microscopic field
(0.04 mm2), the above percentage was calculated by dividing the
total number of cells with double immunopositivity (to CD138 and
IgG4 antibodies; red and green colors, respectively) by the fraction
of elements that showed immunostaining only for CD138 (red
colour), and, then, multiplying that value by 100. In each case, this
sampling was performed by evaluating 30 histological fields (total
tissue area analyzed: 1.2 mm2).
Ultrastructural examination
Eight cases were ultrastructurally analyzed, to confirm the light
microscopy findings and to investigate potentially peculiar ultra-
structural aspects of IRF. Tissue fragments of 2 1 mm were excised
from the samples used for the light microscopy examination and
processed following previously described techniques.63 Thin sections
were examined under a transmission electron microscope (Philips,
EM 208S, Eindhoven, NL).
Statistical analysis
The data are expressed as mean values7s.d. The normal distribu-
tion of the morphometric values was verified using the Kolmogorov–
Smirnov test, and the differences between the different lymphocyte
subsets were assessed by means of one-way analysis of variance and
Student’s t-tests for paired and unpaired data. The differences in
ESR and CRP levels between patients with and without histological
evidence of vasculitis were assessed using Mann–Whitney U-test,
whereas the differences in frequency of autoantibodies and
frequency of renal failure between the above two groups by Fisher’s
exact test. All of the tests were made using SPSS version 14.0
software (SPDD Inc., Chicago, IL), with P-values o0.05 being
considered statistically significant.
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